JPRN-UMIN000005058
Recruiting
未知
Phase II study of S-1 chemotherapy in elderly patients with advanced non-small cell lung cancer harboring no EGFR gene mutation - Phase II study of S-1 chemotherapy in elderly patients with advanced non-small cell lung cancer harboring no EGFR gene mutation (ALCSG 1002)
Respiratory Center, Asahikawa Medical University Hospital0 sites30 target enrollmentFebruary 14, 2011
Conditionson-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Respiratory Center, Asahikawa Medical University Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients are excluded if they have; 1\) severe concomitant diseases, 2\) interstitial pneumonia, 3\) NSCLC with EGFR gene mutations, 4\) no measurable lesion.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II study of perioperative chemotherapy for cStage II and III thoracic esophageal cancerJPRN-jRCTs051200048Kitadani Junya27
Completed
Phase 2
ESOX trialadenocarcinoma of the esophagogastric junctionJPRN-jRCTs051180192Watanabe Masayuki50
Recruiting
Phase 2
A phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in T3/T4a and/or lymph node-positive advanced adenocarcinoma of the esophagogastric junctioJPRN-UMIN000020815Cancer Institute Hospital, Gastroenterological Chemotherapy Department50
Completed
Phase 2
A phase II study of systemic chemotherapy with S-1 and Oxaliplatin followed by gastrectomy with D2 or D2 plus limited para-aortic lymph node dissection in HER2 negative advanced gastric or esophagogastric junction cancer with extensive lymph node metastasisGastric cancerJPRN-UMIN000027506Cancer Institute Hospital35
Active, not recruiting
Phase 2
SOX-D2 studyJPRN-jRCTs051180198Sano Takeshi35